Analyst

I am a pharmaceutical science researcher with a strong background in analytical chemistry, molecular biology, and drug discovery. I completed my Bachelor of Pharmacy from Mawlana Bhashani Science and Technology University with a CGPA of 3.58 (3.72 after SpanTran evaluation). My research interests focus on pharmaceutical analysis, analytical method development and validation, pharmacogenomics, and computational drug discovery. My master’s thesis investigates the association of AGTR1 (rs5186 A>C) polymorphism with cardiovascular disease in the Bangladeshi population, supported by the National Science and Technology (NST) Fellowship (2025–26). I have hands-on industrial experience as a laboratory analyst in a WHO-certified, GMP-compliant pharmaceutical facility, where I perform drug analysis using advanced techniques such as HPLC, GC, FT-IR, UV-Vis spectroscopy, Raman spectroscopy, and atomic absorption spectroscopy. My expertise includes assay analysis, impurity profiling, protein characterization, and analytical troubleshooting. I also received specialized training in GC-MS. My academic and research work includes HPLC method development for cholecalciferol and real-time stability studies. In addition, I am actively engaged in computational drug discovery, including molecular docking, molecular dynamics simulation, and ADMET analysis. I have conducted in silico research on efflux pump inhibition in multidrug-resistant Staphylococcus aureus and co-authored a peer-reviewed publication on dengue virus drug discovery (ChemistrySelect, 2024). I aim to pursue a Ph.D. in pharmaceutical sciences, focusing on analytical method development, biomarker discovery, and early-stage drug discovery, with the long-term goal of contributing as an analytical scientist in the pharmaceutical industry.